A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02859.x/fullpdf
Reference10 articles.
1. Primary dexamethasone treatment for multiple myeloma;Alexanian;Blood,1992
2. Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism;Chauhan;Oncogene,1997
3. Treatment of AL-amyloidosis with dexamethasone plus alpha interferon;Dhodapkar;Leukemia and Lymphoma,1997
4. Phase II trial of recombinant interferon alpha-2 in the treatment of primary systemic amyloidosis;Gertz;American Journal of Hematology,1993
5. Phase II trial of high dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis;Gertz;American Journal of Hematology,1999a
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis;The Journal of Clinical Pharmacology;2021-11-28
2. Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement;PLOS ONE;2021-09-15
3. A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis;Leukemia;2021-06-24
4. Conventional Therapy for Amyloid Light-Chain Amyloidosis;Acta Haematologica;2020
5. Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib;Blood Cancer Journal;2017-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3